LeggoMark vs Kazuya | 55–68 | 44.72% |
LeggoMark vs King | 54–65 | 45.38% |
LeggoMark vs Jin | 55–47 | 53.92% |
LeggoMark vs Law | 47–47 | 50.00% |
LeggoMark vs Dragunov | 45–47 | 48.91% |
LeggoMark vs Bryan | 46–45 | 50.55% |
LeggoMark vs Hwoarang | 61–28 | 68.54% |
LeggoMark vs Reina | 51–37 | 57.95% |
LeggoMark vs Steve | 46–39 | 54.12% |
LeggoMark vs Azucena | 34–37 | 47.89% |
LeggoMark vs Yoshimitsu | 32–33 | 49.23% |
LeggoMark vs Victor | 35–22 | 61.40% |
LeggoMark vs Xiaoyu | 30–26 | 53.57% |
LeggoMark vs Lidia | 33–22 | 60.00% |
LeggoMark vs Heihachi | 24–31 | 43.64% |
LeggoMark vs Eddy | 14–38 | 26.92% |
LeggoMark vs Lee | 16–34 | 32.00% |
LeggoMark vs Jun | 28–21 | 57.14% |
LeggoMark vs Lars | 17–31 | 35.42% |
LeggoMark vs Lili | 22–25 | 46.81% |
LeggoMark vs Leo | 25–22 | 53.19% |
LeggoMark vs Paul | 15–31 | 32.61% |
LeggoMark vs Asuka | 18–21 | 46.15% |
LeggoMark vs Devil Jin | 15–23 | 39.47% |
LeggoMark vs Nina | 18–20 | 47.37% |
LeggoMark vs Jack-8 | 15–20 | 42.86% |
LeggoMark vs Feng | 14–21 | 40.00% |
LeggoMark vs Leroy | 15–17 | 46.88% |
LeggoMark vs Alisa | 8–21 | 27.59% |
LeggoMark vs Claudio | 13–11 | 54.17% |
LeggoMark vs Shaheen | 8–11 | 42.11% |
LeggoMark vs Raven | 8–10 | 44.44% |
LeggoMark vs Kuma | 8–8 | 50.00% |
LeggoMark vs Zafina | 6–9 | 40.00% |
LeggoMark vs Panda | 4–2 | 66.67% |
LeggoMark vs Clive | 1–3 | 25.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.